/SOMNF
SOMNF Stock - SomnoMed Limited
Healthcare|Medical - DevicesOTC
$0.46+0.00%
+$0.00 (+0.00%) • Dec 19
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.60
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.51
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SOMNF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.46 – $0.46
TARGET (TP)$0.53
STOP LOSS$0.42
RISK/REWARD1:1.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.00
52W High$0.48
52W Low$0.17
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $111.49M | $91.65M | $83.62M | $72.58M | $62.71M |
| Gross Profit | $66.73M | $55.13M | $45.77M | $39.15M | $33.90M |
| Gross Margin | 59.9% | 60.2% | 54.7% | 53.9% | 54.1% |
| Operating Income | $3.62M | $-8,329,460 | $-4,072,630 | $-4,131,459 | $-651,380 |
| Net Income | $-3,456,329 | $-12,241,726 | $-7,999,044 | $-4,436,967 | $-1,193,008 |
| Net Margin | -3.1% | -13.4% | -9.6% | -6.1% | -1.9% |
| EPS | $-0.02 | $-0.10 | $-0.10 | $-0.05 | $-0.01 |
Company Overview
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. It offers SomnoDent, an oral appliance for obstructive sleep apnea; SomnoBrux, a dental guard for the treatment of teeth grinding damage; SomMorning Repositioner, which help return mandible back to its pre-treatment centric position; and SomTabs for cleaning oral devices. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SOMNFBeat Rate
38%
Last 16 quarters
Avg Surprise
-139.6%
EPS vs Estimate
Beats / Misses
6/10
Last 12 quarters
Latest EPS
$-0.00
Q1 2025
EPS Surprise History
Q4 22
-16.4%
$-0.02vs$-0.02
Q1 23
-80.3%
$-0.02vs$-0.01
Q2 23
-156.2%
$-0.03vs$-0.01
Q1 24
No data
Q2 24
-239.4%
$-0.04vs$-0.01
Q2 24
No data
Q4 24
-1527.5%
$-0.03vs$-0.00
Q1 25
-187.1%
$-0.00vs$0.00
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 25, 2026 | — | — | — | — |
Q1 2025 | Feb 26, 2025 | $0.00 | $-0.00 | -187.1% | ✗ MISS |
Q4 2024 | Oct 22, 2024 | $-0.00 | $-0.03 | -1527.5% | ✗ MISS |
Q4 2024 | Oct 22, 2024 | — | — | — | — |
Q2 2024 | Apr 29, 2024 | — | $-0.01 | — | — |
Q2 2024 | Apr 29, 2024 | $-0.01 | $-0.04 | -239.4% | ✗ MISS |
Q1 2024 | Jan 29, 2024 | — | $-0.02 | — | — |
Q2 2023 | Jun 30, 2023 | $-0.01 | $-0.03 | -156.2% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-0.01 | $-0.02 | -80.3% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | $-0.02 | $-0.02 | -16.4% | ✗ MISS |
Q3 2022 | Sep 30, 2022 | $-0.02 | $-0.02 | +22.3% | ✓ BEAT |
Q2 2022 | Jun 30, 2022 | $-0.01 | $-0.01 | +18.4% | ✓ BEAT |
Q1 2022 | Mar 31, 2022 | $-0.01 | $-0.01 | +37.3% | ✓ BEAT |
Q4 2021 | Dec 31, 2021 | $-0.01 | $-0.02 | -97.8% | ✗ MISS |
Q3 2021 | Sep 30, 2021 | $-0.01 | $-0.01 | -40.7% | ✗ MISS |
Q2 2021 | Jun 30, 2021 | $0.01 | $-0.01 | -201.8% | ✗ MISS |
Q1 2021 | Mar 31, 2021 | $0.01 | $-0.01 | -173.3% | ✗ MISS |
Q4 2020 | Dec 31, 2020 | $-0.01 | $0.00 | +165.2% | ✓ BEAT |
Q3 2020 | Sep 30, 2020 | $-0.01 | $0.00 | +150.4% | ✓ BEAT |
Q2 2020 | Jun 30, 2020 | $-0.20 | $-0.02 | +92.5% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about SOMNF
What is SOMNF's current stock price?
SomnoMed Limited (SOMNF) is currently trading at $0.46 per share. The stock has moved +0.00% today.
What is the analyst price target for SOMNF?
No analyst price targets are currently available for this stock.
What sector is SomnoMed Limited in?
SomnoMed Limited operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is SOMNF's market cap?
SomnoMed Limited has a market capitalization of $0.10 billion, making it a small-cap company.
Does SOMNF pay dividends?
No, SomnoMed Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAURX
Nuo Therapeutics, Inc.
$2.15
Mkt Cap: $0.1B
CORBF
Global Cord Blood Corporation
$0.75
Mkt Cap: $0.1B
GRUSF
Grown Rogue International Inc.
$0.38
Mkt Cap: $0.1B
LDXHF
Lumos Diagnostics Holdings Limited
$0.17
Mkt Cap: $0.1B
ORXOF
Orexo AB (publ)
$3.05
Mkt Cap: $0.1B
PFGTF
Pacific Edge Limited
$0.10
Mkt Cap: $0.1B
SHIEF
Shield Therapeutics plc
$0.09
Mkt Cap: $0.1B
SNZZF
Senzime AB (publ)
$0.45
Mkt Cap: $0.1B
TOKIF
Optima Medical Innovations Corp.
$0.01
Mkt Cap: $0.1B
VTIAF
FamiCord AG
$6.38
Mkt Cap: $0.1B
Explore stocks similar to SOMNF for comparison